摘要:
A portable analytical device is provided for analysis of a component of a body fluid. A measuring facility within the device may carry out the analysis on a test element inserted therein. The test element may contain a reagent that reacts with a liquid sample of the body fluid when the test element is contacted thereby to produce a change that is characteristic of the analysis. A processor may process measuring values determined by the measuring facility to yield analytical measuring data taking into account calibration values. A standardized, wire-based computer interface may be provided on the analytical device via which the analytical device can be operated by a computer, the analytical measuring data can be transmitted from the analytical device to the computer, the analytical device can be supplied with electrical power by the computer, and the analytical device can provide software to be read-out by the computer.
摘要:
The present application discloses systems and methods for adjusting a back-off value for a rank. In some embodiment, the method includes the steps of: (a) determining whether the rank is underutilized and (b) in response to determining that the rank is underutilized, decreasing the back-off value as a function of time while the rank remains underutilized.
摘要:
The present application discloses systems and methods for adjusting a back-off value for a rank. In some embodiment, the method includes the steps of: (a) determining whether the rank is underutilized and (b) in response to determining that the rank is underutilized, decreasing the back-off value as a function of time while the rank remains underutilized.
摘要:
Glucose analysis instrument for diabetics, comprising a measuring device for determining glucose concentration values, a displaying device for displaying glucose concentration values, a signaling device for generating a reminder signal, and a control and evaluation device that comprises a processor and a data memory and is used to determine reminder times at which the signaling device is actuated. Event data are stored in the data memory, the event data containing information on events occurring in the life of a user of the glucose analysis instrument and on the time of occurrence of such events. The reminder times are determined by means of a reminder time determination algorithm taking into consideration event data from at least one previous day.
摘要:
A system for analysing a fluid sample arranged on a test element comprises a data processing unit configured to process results of an analysis of the fluid sample arranged on the test element, an audible signal generator, and a control unit. The control unit may control the audible signal generator to generate an audible test signal that is configured to test the operability of the signal generator to audibly encode information. The audible test signal may include audible features that allow for identification of any deviation of the generated audible test signal from a correctly generated audible test signal, and/or from which malfunction of the signal generator can be detected.
摘要:
A handheld analysis device for examining a sample of body fluid, such as blood to analyze blood glucose, has a setting mode for changing various device settings to improve the changing of device settings. The handheld analysis device comprises a measurement unit, a microprocessor, a segment display, and an operating element. When the operating element is actuated, the device is placed in a selection mode and further actuation of the operating element, then in one of several setting modes, the user can efficiently change device settings by inputting data and/or control commands.
摘要:
In particular for the measurement of blood glucose concentrations, portable diagnostic devices are disclosed that are user-friendly and safe to handle. A method is proposed which controls the range of functions of diagnostic devices and avoids incorrect operation of diagnostic devices of this kind, by substantially preventing unintentional and unnoticed alteration of critical parameters, typically system time and/or system date. The method includes a key-recognition step and an enable step. The key-recognition step determines whether at least one key module is connected to the diagnostic device. Depending on whether such a connection exists, the alteration of at least one critical parameter stored and/or generated in the diagnostic device is permitted or prevented in the enable step. A diagnostic device on which the method according to the invention can be implemented in one of its embodiments is also proposed, as is a corresponding key module, and also a diagnostic system which comprises a diagnostic device and at least one key module.
摘要:
Glucose analysis instrument for diabetics, comprising a measuring device for determining glucose concentration values, a displaying device for displaying glucose concentration values, a signaling device for generating a reminder signal, and a control and evaluation device that comprises a processor and a data memory and is used to determine reminder times at which the signaling device is actuated. Event data are stored in the data memory, the event data containing information on events occurring in the life of a user of the glucose analysis instrument and on the time of occurrence of such events. The reminder times are determined by means of a reminder time determination algorithm taking into consideration event data from at least one previous day.
摘要:
The present invention provides a novel process for producing sterile suspensions of slightly soluble basic peptide complexes. The present invention further provides a novel process for producing sterile lyophilizates of slightly soluble basic peptide complexes. In addition, a novel process for producing sterile suspensions suitable for the parenteral administration of slightly soluble basic peptide complexes is provided. The invention moreover provides sterile suspensions and sterile lyophilizates of slightly soluble basic peptide complexes, and pharmaceutical formulations comprising them. The provided sterile suspensions, sterile lyophilizates and pharmaceutical formulations comprising them are particularly suitable for use in a parenteral dosage form as medicaments for the treatment and prophylaxis of diseases and pathological states in mammals, especially in humans.